20-443 New Prior Authorization Requirements
Date: 06/08/20
Request prior authorizations for medications listed in this update
Please review the medications in this update to find out when you need to request prior authorization (PA) for California Health & Wellness Plan (CHWP) members.
Medications requiring PA immediately
The below medications require PA immediately per new injectable medication HCPCS codes issued by the Centers for Medicare & Medicaid Services (CMS) on April 1, 2020:
- Adakveo®
- Givlaari®
New PA requirements starting August 11, 2020
All providers must request PA for the medications listed below:
Erbitux® | Ozurdex® | Triptodur® | Vyondys 53® |
Faslodex® | Panhematin® | Vectibix® | Zaltrap® |
Mozobil® | Synribo® | Vidaza® |
|
View PA requirements online
Prior authorization requirements are available on www.CAHealthWellness.com.
Providers participating through the Community Care Independent Practice Association (CCIPA) must contact CCIPA, follow CCIPA’s prior authorization process and use CCIPA’s forms.
Additional information
If you have questions regarding the information contained in this update, contact CHWP at 1-877-658-0305.